2024-11-29 00:51:00
Ocumension OT-401 (Product  name: YUTIO),  a treatment for chronic non-infectious uveitis officially approved for marketing by the National Medical Products Administration
Corporate/ 2023-07-24
Ocumension OT-401 (Product name: YUTIO)...

BEIJING,June 23,2022--Ocumension Therapeutics (1477.HK)announced that the New Drug Application (NDA) for the core product in its pipeline,...

How Can Digitalization of Medical Devices Boost Productivity in Med-tech
Health/ 2023-07-22
How Can Digitalization of Medical Device...

The digital transformation of medical devices encourages medtech players to deliver significant value for providers and patients,says Frost ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release